CN Stock MarketDetailed Quotes
300791 Sirio Pharma
- 29.91
- +0.15+0.50%
Market Closed Dec 13 15:00 CST
7.05BMarket Cap21.02P/E (TTM)
30.41High29.01Low55.77KlotVolume29.62Open29.76Pre Close165.75MTurnover2.87%Turnover Ratio25.11P/E (Static)235.87MShares35.4852wk High3.17P/B5.81BFloat Cap18.5152wk Low35.71Limit Up194.38MShs Float62.28Historical High23.81Limit Down4.70%Amplitude13.86Historical Low0.85Dividend TTM29.72Avg Price24.78KlotAsk2.84%Div YieldTTM100Lot Size27.91KlotBid
Sirio Pharma Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 22.86%3.05B | 22.46%1.92B | 9.91%918.34M | 32.02%3.44B | 22.28%2.48B | 30.17%1.57B | 37.65%835.52M | 6.52%2.6B | 9.91%2.03B | 1.20%1.2B |
| Refunds of taxes and levies | 5.25%34.79M | -18.94%16.71M | 13.67%6.43M | -49.19%43.56M | -47.59%33.06M | -60.41%20.62M | -47.33%5.65M | 221.44%85.73M | 85.18%63.07M | 162.11%52.08M |
| Cash received relating to other operating activities | 307.08%53.55M | -19.72%7.05M | -96.60%3.56M | 19.51%24.75M | -49.14%13.16M | -40.26%8.78M | 963.21%104.55M | 29.44%20.71M | 21.37%25.87M | 23.22%14.69M |
| Cash inflows from operating activities | 24.10%3.14B | 21.70%1.94B | -1.84%928.32M | 29.35%3.5B | 19.33%2.53B | 25.64%1.6B | 50.70%945.73M | 8.97%2.71B | 11.39%2.12B | 4.03%1.27B |
| Goods services cash paid | 26.18%1.78B | 15.41%1.07B | 32.04%634.37M | 17.86%1.88B | 21.52%1.41B | 41.08%922.87M | 71.14%480.45M | 12.06%1.59B | 13.41%1.16B | -4.25%654.15M |
| Staff behalf paid | 27.88%589.8M | 58.17%493.04M | -13.96%216.34M | 76.48%725.68M | 56.88%461.22M | 51.24%311.71M | 123.46%251.43M | -1.77%411.19M | 6.58%293.99M | 10.05%206.11M |
| All taxes paid | 8.56%99.69M | 2.70%62.51M | 7.68%29.84M | 39.11%132.01M | 28.09%91.83M | 23.43%60.86M | 46.15%27.71M | -15.06%94.89M | -17.24%71.69M | -11.96%49.31M |
| Cash paid relating to other operating activities | 42.14%379.57M | 28.76%207.53M | -19.01%120.07M | 132.08%382.75M | 9.60%267.04M | 9.97%161.17M | 94.77%148.26M | -14.39%164.92M | 13.61%243.66M | 7.48%146.56M |
| Cash outflows from operating activities | 27.71%2.85B | 25.51%1.83B | 10.22%1B | 37.71%3.12B | 26.01%2.23B | 37.92%1.46B | 85.90%907.85M | 5.57%2.26B | 10.61%1.77B | -0.63%1.06B |
| Net cash flows from operating activities | -3.43%282.53M | -18.14%114.18M | -290.87%-72.3M | -13.21%386.08M | -15.07%292.57M | -34.89%139.49M | -72.79%37.88M | 30.31%444.86M | 15.59%344.49M | 35.29%214.22M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -13.29%321.64M | 82.73%310.64M | 41.22%70.72M | -79.59%579.4M | --370.94M | --170M | --50.08M | 114.67%2.84B | ---- | ---- |
| Cash received from returns on investments | -86.34%1.63M | 361.81%3.87M | ---- | -90.74%2.22M | 19.45%11.96M | -90.09%837.86K | ---- | -10.40%23.97M | -14.00%10.01M | 6.13%8.45M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -89.31%31K | 26,062.40%152.96K | ---- | --2.74M | 11,495.46%289.89K | --584.66 | ---- | ---- | -90.38%2.5K | ---- |
| Cash received relating to other investing activities | -91.66%12.48M | -89.02%10.96M | 2,103.69%32.49M | --99.6M | -90.35%149.68M | -85.95%99.88M | -99.08%1.47M | ---- | 41.81%1.55B | 5.70%710.68M |
| Cash inflows from investing activities | -36.98%335.79M | 20.28%325.62M | 100.19%103.21M | -76.11%683.95M | -65.88%532.87M | -62.35%270.72M | -67.99%51.56M | 112.12%2.86B | 41.21%1.56B | 5.70%719.13M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -15.94%271.21M | -5.07%176.52M | -16.48%105.47M | 53.80%451.7M | 36.46%322.64M | 7.31%185.94M | 14.17%126.29M | -44.02%293.69M | -38.69%236.45M | -23.56%173.28M |
| Cash paid to acquire investments | -43.33%170M | -15.00%170M | -45.12%54.88M | -68.39%682.57M | --300M | --200M | --100M | 38.36%2.16B | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --707.54M | --782.27M | --782.27M | --419.82M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | -93.10%18.96M | ---- | -75.69%20M | ---- | -80.29%274.84M | -87.21%84.58M | -65.94%82.26M | --126.37M | 22.82%1.39B | 12.81%661.49M |
| Cash outflows from investing activities | -72.60%460.17M | -72.34%346.52M | -75.24%180.36M | -28.60%1.84B | 3.02%1.68B | 50.08%1.25B | 106.86%728.38M | 23.69%2.58B | 7.22%1.63B | 2.67%834.77M |
| Net cash flows from investing activities | 89.15%-124.38M | 97.87%-20.89M | 88.60%-77.14M | -507.83%-1.16B | -1,564.70%-1.15B | -749.25%-982.07M | -254.31%-676.82M | 138.60%283.91M | 83.39%-68.89M | 12.84%-115.64M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --2.22M | --3.1M | ---- | 105.03%13.54M | ---- | ---- | ---- | 97.28%6.6M | 97.28%6.6M | ---- |
| Cash from borrowing | 149.35%125.06M | --100.91M | --59.44M | 286,901.79%97.22M | --50.16M | ---- | ---- | -100.00%33.88K | ---- | ---- |
| Cash received relating to other financing activities | --1.98K | --14.47M | ---- | 242.80%3.34M | ---- | ---- | ---- | --972.91K | ---- | ---- |
| Cash inflows from financing activities | 153.79%127.29M | --118.49M | --59.44M | 1,399.50%114.09M | 659.72%50.16M | ---- | ---- | -99.25%7.61M | -99.35%6.6M | ---- |
| Borrowing repayment | 214.82%22.19M | 158.90%18.25M | -93.34%17.27M | --155.7K | --7.05M | --7.05M | --259.19M | ---- | ---- | ---- |
| Dividend interest payment | 213.00%222.6M | 198.46%212.12M | --1.75M | 10.18%83.83M | -4.16%71.12M | -4.22%71.07M | ---- | 4.90%76.09M | 5.24%74.2M | 5.44%74.2M |
| Cash payments relating to other financing activities | -80.11%8.32M | 13.14%20.23M | 476.18%12.07M | 1,187.44%121.26M | 892.61%41.81M | 552.05%17.88M | 46.83%2.09M | 5.55%9.42M | 130.20%4.21M | 31.02%2.74M |
| Cash outflows from financing activities | 110.96%253.11M | 161.04%250.59M | -88.10%31.08M | 140.03%205.24M | 53.01%119.98M | 24.76%96M | 18,219.12%261.28M | -24.60%85.51M | 7.20%78.42M | 6.17%76.94M |
| Net cash flows from financing activities | -80.20%-125.82M | -37.62%-132.11M | 110.85%28.35M | -17.01%-91.15M | 2.77%-69.82M | -24.76%-96M | -18,219.12%-261.28M | -108.60%-77.9M | -107.57%-71.81M | -108.15%-76.94M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -101.32%-125.01K | -94.89%452.5K | 325.44%3.01M | -115.37%-4.59M | -13.27%9.47M | -10.59%8.85M | -145.20%-1.33M | 364.91%29.86M | 652.13%10.92M | 520.60%9.9M |
| Net increase in cash and cash equivalents | 103.52%32.21M | 95.87%-38.37M | 86.90%-118.09M | -227.44%-867.52M | -526.00%-914.66M | -3,047.97%-929.73M | -1,576.96%-901.56M | 35.94%680.72M | -74.12%214.71M | -96.74%31.54M |
| Add:Begin period cash and cash equivalents | -62.44%521.94M | -62.44%521.94M | -62.44%521.94M | 96.05%1.39B | 96.05%1.39B | 96.05%1.39B | 96.05%1.39B | 240.75%708.73M | 240.75%708.73M | 240.75%708.73M |
| End period cash equivalent | 16.71%554.14M | 5.19%483.57M | -17.23%403.85M | -62.44%521.94M | -48.58%474.8M | -37.90%459.73M | -25.51%487.9M | 96.05%1.39B | -11.00%923.44M | -37.00%740.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
